Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study-Reference-Cited by-同舟云学术

Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study

Published:2016-09 Issue:9 Volume:18 Page:532-538
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Šoupal Jan¹,Petruželková Lenka²,Flekač Milan¹,Pelcl Tomáš¹,Matoulek Martin¹,Daňková Martina¹,Škrha Jan¹,Svačina Štěpán¹,Prázný Martin¹

Affiliation:

1. 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, Czech Republic.

2. Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2016.0171

Reference20 articles.

1. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

2. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

3. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

4. Glycemic Variability Is Higher in Type 1 Diabetes Patients with Microvascular Complications Irrespective of Glycemic Control

5. Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-monitoring in children with type 1 diabetes mellitus;Pediatrie pro praxi;2024-09-05

2. Accuracy and precision of the certified Glucometer-Strips Systems Galileo, Calla and Contour Plus One in clinical practice;2024-08-17

3. Modifiable factors to prevent severe hypoglycaemic and diabetic ketoacidosis presentations in people with type 1 diabetes;Diabetic Medicine;2024-06-24

4. Identifying the deficiencies of currently available CGM to improve uptake and benefit;Diabetic Medicine;2024-05-12

5. Digital biomarkers: 3PM approach revolutionizing chronic disease management — EPMA 2024 position;EPMA Journal;2024-05-11